MastOnorm® , an oral product derived from botanical ingredients, is intended to eliminate the effects of fibrocystic breast disease (FBD). There is no currently approved therapy for the treatment of FBD.
A total of 488 ambulatory patients at the Georgian National Center of Oncology (Tbilisi, Georgia) participated in a clinical trial. The patients received two pills of the herbal complex twice a day during a 12-week period. At the completion of the treatment, the following was observed:
Reduction of breast pain in 100% of study subjects
Reduction of breast swelling and tenderness in 97.54%
Reduction of breast nodularity in 95.29%
Reduction of palpable breast lumps in 89.8%
Reduction of nipple discharge in 95.69%
Reduction of breast inflammation in 96.78%
PHYTOTHERAPEUTIC PRODUCT FOR CORRECTION OF SYMPTOM-COMPLEX OF FIBROCYSTIC CHANGES OF MAMMARY GLAND
Contact Us View In-Vivo & In-Vitro Clinical Report
